Article Details

Capsida Biotherapeutics Debuts with $140 Million of Capital

Retrieved on: 2021-04-29 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

Capsida Biotherapeutics Debuts with $140 Million of Capital. View article details on hiswai:

Excerpt

The platform uses machine learning, structural biology, non-human primate models, and human tissue models to screen billions of engineered ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up